Top Markets
Coin of the day
Clarity Pharmaceuticals Ltd Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd

CU6
株式のランク #11775
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company,... Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
株価
$1.77
最終同期: 2026-08-28
時価総額
$660.45M
変化(1日)
7.26%
変化(1年)
-9.15%
AU
取引 Clarity Pharmaceuticals Ltd (CU6)

カテゴリー

Clarity Pharmaceuticals Ltd(CU6)の株価履歴
終値の最高値: $1.83 (2026-08-01)

終値の最安値: $1.06 (2021-08-01)
Clarity Pharmaceuticals Ltd の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 4.14%
2025 -32.14%
2024 182.71%
2023 71.64%
2022 17.37%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$233.52 -4.71%
IE
$15.30 -23.07%
CN
$520.74 6.34%
CH
$164.39 -9.49%
CH
$2.30 -28.59%
CN